Profil de l'entreprise · Healthcare

Hangzhou Tigermed Consulting

300347 · Shenzhen
Bourse
Shenzhen
Pays / Région
China
Date d'introduction en bourse
17 août 2012
Effectif
11 130
Cours actuel
¥51.9
En direct · 15 juillet 2026
Achat raisonnable
≤ ¥27
Point d'entrée avec marge de sécurité
Score de croissance Baillie
44/100
Faible
Valeur intrinsèque · Fourchette en trois niveaux Cours actuel ¥51.9 En direct · Dans la fourchette de valeur intrinsèque raisonnable

Fourchette de valorisation composite · prudent ¥24–¥27 / raisonnable ¥43–¥58 / optimiste ¥79–¥86. À ¥51.9, Dans la fourchette de valeur intrinsèque raisonnable.

Capitalisation39,86 Md CNY
Chiffre d'affaires (TTM)7,07 Md CNY
EBITDA824,11 M CNY
Marge nette10,91 %
ROE4,23 %
PER (TTM)50,87
PER prévisionnel28,99
PEG0
BPA0,91 CNY
Rendement du dividende0,27 %
Fourchette sur 52 semaines35,47 CNY – 71,69 CNY

Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.

Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Historique

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Position dans le secteur

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Pas encore d'analyse sur cette valeur dans votre langue.